KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Shares Outstanding (Weighted Average): 2017-2025

Historic Shares Outstanding (Weighted Average) for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $60.4 million.

  • Twist Bioscience's Shares Outstanding (Weighted Average) rose 3.03% to $60.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.4 million, marking a year-over-year increase of 3.03%. This contributed to the annual value of $60.4 million for FY2025, which is 3.03% up from last year.
  • Per Twist Bioscience's latest filing, its Shares Outstanding (Weighted Average) stood at $60.4 million for Q3 2025, which was up 0.74% from $59.9 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's Shares Outstanding (Weighted Average) registered a high of $60.4 million during Q3 2025, and its lowest value of $48.6 million during Q1 2021.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $58.5 million, with a median of $58.2 million in 2024.
  • Data for Twist Bioscience's Shares Outstanding (Weighted Average) shows a peak YoY soared of 37.24% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Twist Bioscience's Shares Outstanding (Weighted Average) stood at $49.6 million in 2021, then climbed by 13.97% to $56.6 million in 2022, then increased by 1.95% to $57.7 million in 2023, then rose by 2.92% to $59.4 million in 2024, then climbed by 3.03% to $60.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $60.4 million for Q3 2025, versus $59.9 million for Q2 2025 and $59.7 million for Q1 2025.